| scholarly article | Q13442814 |
| P50 | author | Bettina Hansen | Q40007319 |
| Maikel P Peppelenbosch | Q51363232 | ||
| Leendert Looijenga | Q61297057 | ||
| P2093 | author name string | G M Fuhler | |
| M J Bruno | |||
| K Biermann | |||
| Ajm Gillis | |||
| H Braat | |||
| W K Utomo | |||
| P2860 | cites work | Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer | Q95383732 |
| MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer | Q21261323 | ||
| MicroRNA miR-155 is a biomarker of early pancreatic neoplasia | Q24649254 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Cancer biomarkers | Q26864429 | ||
| Circulating microRNAs in hematological diseases: principles, challenges, and perspectives | Q27028135 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer | Q28273473 | ||
| Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue | Q28730615 | ||
| The MicroRNA Spectrum in 12 Body Fluids | Q29618068 | ||
| MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. | Q30541314 | ||
| A combination of molecular markers and clinical features improve the classification of pancreatic cysts | Q30724746 | ||
| Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas | Q33754040 | ||
| Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion | Q34141549 | ||
| Reference miRNAs for miRNAome analysis of urothelial carcinomas | Q34321313 | ||
| MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma | Q34604367 | ||
| MicroRNAs: novel biomarkers for human cancer | Q34952989 | ||
| Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions | Q35087934 | ||
| Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma | Q35123631 | ||
| Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients | Q35494053 | ||
| Cytopathological Analysis of Cyst Fluid Enhances Diagnostic Accuracy of Mucinous Pancreatic Cystic Neoplasms | Q36194506 | ||
| International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas | Q36331064 | ||
| Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization | Q36467712 | ||
| miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts | Q36541286 | ||
| Viruses, microRNAs, and host interactions | Q36753937 | ||
| Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts | Q37483711 | ||
| High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations | Q37771750 | ||
| International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Q38017783 | ||
| Clinical Applications for microRNAs in Cancer | Q38065062 | ||
| The validity of circulating microRNAs in oncology: five years of challenges and contradictions. | Q38198366 | ||
| The emerging role of microRNAs and nutrition in modulating health and disease | Q38230577 | ||
| Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study | Q39341924 | ||
| Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study | Q47635370 | ||
| American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts | Q50575965 | ||
| Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients | Q51464151 | ||
| Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesions | Q51814893 | ||
| Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients | Q53080380 | ||
| Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas | Q53198097 | ||
| Evaluation of Cyst Fluid CEA Analysis in the Diagnosis of Mucinous Cysts of the Pancreas | Q57845830 | ||
| Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study | Q83202075 | ||
| Cyst Fluid Carcinoembryonic Antigen Is an Accurate Diagnostic Marker of Pancreatic Mucinous Cysts | Q84580136 | ||
| Management of pancreatic cysts: the evidence is not here yet | Q86842519 | ||
| Managing pancreatic cysts: less is more? | Q86842531 | ||
| Management of pancreatic cysts in an evidence-based world | Q86842533 | ||
| First microRNA mimic enters clinic | Q87067042 | ||
| MicroRNA biomarkers in whole blood for detection of pancreatic cancer | Q87140824 | ||
| P921 | main subject | microRNA | Q310899 |
| pancreatic cyst | Q25324230 | ||
| P304 | page(s) | e350 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Molecular Therapy. Nucleic acids | Q27724110 |
| P1476 | title | A MicroRNA Panel in Pancreatic Cyst Fluid for the Risk Stratification of Pancreatic Cysts in a Prospective Cohort | |
| P478 | volume | 5 |
Search more.